Primary Human Cells & Specialized Assays

The Food and Drug Administration is forecasting a requirement for the procurement of primary human cells, tissue sourcing, and general assay kits. This initiative emphasizes the necessity of high-quality human cells to ensure the production of physiologically relevant and actionable data. The opportunity is categorized under NAICS code 325414 and is managed by the Food and Drug Administration. Interested parties may coordinate with the Cber Acquisition Liaison for further program details as the contracting officer is yet to be determined.